Stocktoria

Enlivex Ltd. ENLV

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-07-30

Enlivex Ltd. statistics & valuation

Market cap$137.4M
P / E0.1×
P / B0.1×
Return on equity63.9%
Return on capital-0.6%
Graham number +3615.2%$68.36

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($68.36); a green figure means the price is below it.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-102.40% -29.50% -43.70% -83.20% -33.30% -17.00% -54.60% -96.60% -63.60% 63.90% 2016201720182019202020212022202320242025
Shares outstanding
16.4M 3.5M 3.5M 10.3M 14.6M 18.3M 18.4M 18.6M 23.7M 237.4M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-27.10% -26.20% -38.40% -53.40% -29.30% -15.20% -45.90% -78.90% -54.20% 53.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.90 -$0.81 -$1.69 -$1.56 -$0.73 $25.48 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets53.1%-54.2%-78.9%-45.9%-15.2%-29.3%-53.4%-38.4%-26.2%-27.1%
Return on equity63.9%-63.6%-96.6%-54.6%-17.0%-33.3%-83.2%-43.7%-29.5%-102.4%
Current ratio193.246.845.577.9218.328.722.759.0913.095.46

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.